The purpose of the Cellular and Animal Modeling Core is to provide both tissues and tissue processing and afacility for the development of novel epithelial cell lines from the intestinal tissues of transgenic mice. Thefocus of the core's efforts will be on intestinal diseases with the intent to improve human health throughadvances in prevention, diagnosis, or prevention of digestive diseases. The core has two components: theNovel Cell Line Development Subcore and the Tissue Morphology Subcore.The Novel Cell Line Development Subcore provides a unique service in developing conditionallyimmortalized epithelial cell lines from the different segments of the gastrointestinal tract of transgenic micewith gene deletions known to be associated with known gastrointestinal pathologies. One of the majorimpediments in gastrointestinal research has been the lack of normal epithelial cell lines derived fromintestinal mucosa. This subcore addresses this lack by utilizing a novel transgenic mouse, the'Immortomouse,' which carries a temperature-sensitive mutant of the SV40 large T gene, which is animmortalizing gene. The temperature-sensitive form of this gene is only active at the permissive temperature(33 C) and is inactivated by incubation at 39 C. This means that primary cells isolated from the intestinalepithelium can be immortalized by incubation at the permissive temperature but then reverted to a normalphenotype by increasing the incubation temperature to 39 C. The introduction of this immortalizing gene intothe transgenic mouse of interest is achieved by mating a transgenic mouse with the Immortomouse. Aftertwo rounds of mating, mice homozygous for the transgene or knockout phenotype and carrying theimmortalizing gene are obtained. Tissues from these animals can then be cultured using techniquespublished by the core director. To date these methods have been successfully used to develop 50 epithelialcell lines from different gastrointestinal tissues, including stomach, small intestine, colon, pancreas, and liverfrom 10 different transgenic mice. The Tissue Morphology Subcore provides services for the acquisition ofhuman intestinal tissue and for the histologic processing of both human and animal intestinal tissue. Inaddition, Dr. Washington, the core Director, provides the necessary expertise for interpretation of thehistologic findings obtained in these studies. The availability of a central service such as this with allspecimens being processed by one highly skilled histology technician enhances the findings from the othercores, as it provides a level of consistency in the interpretation of histologic changes found in the animalmodels being used by members of the VDDRC. In addition, this subcore provides a supply of high quality,rapidly processed human specimens as required by the VDDRC investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK058404-06
Application #
7283911
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (J1))
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
6
Fiscal Year
2007
Total Cost
$207,126
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Pollins, Alonda C; Boyer, Richard B; Nussenbaum, Marlieke et al. (2018) Comparing Processed Nerve Allografts and Assessing Their Capacity to Retain and Release Nerve Growth Factor. Ann Plast Surg 81:198-202
Ruiz, Rachel M; Sommer, Evan C; Tracy, Dustin et al. (2018) Novel patterns of physical activity in a large sample of preschool-aged children. BMC Public Health 18:242
Scoville, Elizabeth A; Allaman, Margaret M; Brown, Caroline T et al. (2018) Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling. Metabolomics 14:
Loh, John T; Beckett, Amber C; Scholz, Matthew B et al. (2018) High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins. Infect Immun 86:
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
Noto, Jennifer M; Chopra, Abha; Loh, John T et al. (2018) Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments. Gut 67:1793-1804
Kroh, Heather K; Chandrasekaran, Ramyavardhanee; Zhang, Zhifen et al. (2018) A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells. J Biol Chem 293:941-952
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Kohl, Kevin D; Dearing, M Denise; Bordenstein, Seth R (2018) Microbial communities exhibit host species distinguishability and phylosymbiosis along the length of the gastrointestinal tract. Mol Ecol 27:1874-1883

Showing the most recent 10 out of 1365 publications